OneMedNet Income Statement (2021-2026) | ONMD

Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.26M0.20M0.17M0.33M0.34M0.25M0.23M0.14M0.03M0.14M0.15M0.18M0.89M0.10M
Cost of Revenue (Quarter)
0.41M0.29M0.31M0.24M0.30M0.23M0.33M0.23M0.21M0.36M0.26M0.40M0.14M0.38M
Gross Profit (Quarter)
-0.14M-0.09M-0.06M0.03M0.00M-0.07M-0.10M-0.08M-0.03M-0.22M-0.24M-0.22M0.17M-0.38M
Operating items
Research & Development (Quarter)
0.88M0.58M0.58M0.41M0.50M0.45M0.38M0.30M0.34M0.35M0.38M0.32M0.44M0.31M
Selling, General & Administrative (Quarter)
2.77M0.54M0.62M1.31M1.07M1.36M1.72M1.81M2.14M1.36M1.18M1.39M2.38M1.48M
Other Operating Expenses (Quarter)
0.07M0.10M0.25M0.56M0.74M0.47M1.93M0.26M0.31M0.24M0.30M0.23M0.25M0.14M0.21M0.29M0.26M0.30M0.43M0.38M
Operating Expenses (Quarter)
0.07M0.10M0.25M0.56M0.74M0.47M5.58M1.38M1.51M1.96M1.87M2.03M2.35M2.25M2.69M2.00M1.82M2.01M3.25M2.17M
Operating Income (Quarter)
-0.07M-0.10M-0.42M-0.61M-0.79M-0.52M-5.79M-1.47M-1.57M-1.93M-1.87M-2.10M-2.45M-2.34M-2.72M-2.22M-2.06M-2.23M-3.08M-2.55M
EBIT (Quarter)
-0.07M-0.10M-0.42M-0.61M-0.79M-0.52M-5.79M-1.47M-1.57M-1.93M-1.87M-2.10M-2.45M-2.34M-2.72M-2.22M-2.06M-2.23M-3.08M-2.55M
Non-operating items
Non Operating Investment Income (Quarter)
0.16M
Interest & Investment Income (Quarter)
794.000.00M-0.00M
Other Non Operating Income (Quarter)
-0.01M-0.03M-0.01M0.01M0.01M-0.02M0.16M-0.04M0.32M-0.01M-0.01M0.18M0.18M
Non Operating Income (Quarter)
-0.63M-0.30M-22.42M-6.36M-8.03M-0.01M26.27M-0.01M-0.02M-0.00M-0.51M0.32M-0.01M1.49M6.82M0.10M
Net income details
EBT (Quarter)
-0.07M1.29M-0.46M2.20M0.95M-0.05M-33.55M-0.03M0.06M-0.73M-33.13M-2.14M-2.50M-2.37M-2.74M-2.25M-2.08M-2.24M-3.09M-2.56M
Tax Provisions (Quarter)
0.11M-0.09M0.06M0.06M0.09M-0.19M
Profit After Tax (Quarter)
4.31M1.29M-0.46M2.20M0.95M-0.15M-33.44M-7.84M-9.60M-13.84M-2.50M-2.11M-3.59M-2.06M-2.37M-1.90M2.98M-0.74M-3.14M-2.45M
Income from Continuing Operations (Quarter)
-0.07M1.29M-0.46M2.20M0.95M-0.15M-33.47M-0.09M-0.01M-0.82M-32.94M-2.14M-2.50M-2.37M-2.74M-2.25M-2.08M-2.24M-3.09M-2.56M
Consolidated Net Income (Quarter)
-0.07M1.29M-0.46M2.20M0.95M-0.15M-33.47M-0.09M-0.01M-0.82M-32.94M-2.14M-2.50M-2.37M-2.74M-2.25M-2.08M-2.24M-3.09M-2.56M
Income towards Parent Company (Quarter)
-0.07M1.29M-0.46M2.20M0.95M-0.15M-33.47M-0.09M-0.01M-0.82M-32.94M-2.14M-2.50M-2.37M-2.74M-2.25M-2.08M-2.24M-3.09M-2.56M
Net Income towards Common Stockholders (Quarter)
-0.07M1.29M-0.46M2.20M0.95M-0.15M-33.47M-0.09M-0.01M-0.82M-32.94M-2.14M-3.59M-2.06M-2.74M-2.25M2.76M-0.74M-3.09M-2.56M
Additional items
EPS (Basic) (Quarter)
0.450.09-0.110.150.060.01-7.86-1.94-2.38-3.232.91-0.08-0.14-0.07-0.07-0.060.07-0.01-0.07-0.04
EPS (Weighted Average and Diluted) (Quarter)
0.450.09-0.110.150.060.01-7.86-1.94-2.38-3.232.91-0.08-0.14-0.07-0.07-0.060.07-0.01-0.07-0.04
Shares Outstanding (Weighted Average) (Quarter)
3.20M11.50M3.30M11.50M11.50M11.50M3.97M2.73M4.84M4.28M7.27M24.92M25.18M29.27M14.43M14.43M36.84M41.25M14.34M55.32M
Shares Outstanding (Diluted Average) (Quarter)
3.20M7.00M8.26M3.46M11.50M11.50M3.97M4.03M4.03M4.28M7.27M24.92M25.18M26.34M28.08M34.10M37.13M42.97M44.55M55.32M
EBITDA (Quarter)
-0.07M-0.10M-0.42M-0.61M-0.79M-0.52M-5.79M-1.47M-1.57M-1.93M-1.87M-2.10M-2.45M-2.34M-2.72M-2.22M-2.06M-2.23M-3.08M-2.55M
Interest Expenses (Quarter)
58.00-0.03M0.04M0.04M0.04M0.03M0.03M0.02M0.01M0.01M0.01M
Tax Rate (Quarter)
-229.26%0.27%-225.88%108.96%-12.04%0.58%